ITCI
LPL Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,219
| Closed | -$820K | – | 5528 |
|
|
2025
Q1 | $820K | Sell |
6,219
-22,039
| -78% | -$2.91M | ﹤0.01% | 3688 |
|
|
2024
Q4 | $2.36M | Buy |
28,258
+7,878
| +39% | +$658K | ﹤0.01% | 2698 |
|
|
2024
Q3 | $1.49M | Buy |
20,380
+9,820
| +93% | +$719K | ﹤0.01% | 2976 |
|
|
2024
Q2 | $723K | Buy |
10,560
+1,366
| +15% | +$93.6K | ﹤0.01% | 3500 |
|
|
2024
Q1 | $636K | Buy |
9,194
+266
| +3% | +$18.4K | ﹤0.01% | 3539 |
|
|
2023
Q4 | $639K | Sell |
8,928
-462
| -5% | -$33.1K | ﹤0.01% | 3419 |
|
|
2023
Q3 | $489K | Buy |
9,390
+1,387
| +17% | +$72.2K | ﹤0.01% | 3477 |
|
|
2023
Q2 | $507K | Buy |
8,003
+90
| +1% | +$5.7K | ﹤0.01% | 3410 |
|
|
2023
Q1 | $428K | Sell |
7,913
-683
| -8% | -$37K | ﹤0.01% | 3440 |
|
|
2022
Q4 | $455K | Sell |
8,596
-645
| -7% | -$34.1K | ﹤0.01% | 3319 |
|
|
2022
Q3 | $430K | Buy |
9,241
+249
| +3% | +$11.6K | ﹤0.01% | 3276 |
|
|
2022
Q2 | $513K | Sell |
8,992
-2,450
| -21% | -$140K | ﹤0.01% | 3159 |
|
|
2022
Q1 | $700K | Sell |
11,442
-2,799
| -20% | -$171K | ﹤0.01% | 2907 |
|
|
2021
Q4 | $745K | Sell |
14,241
-676
| -5% | -$35.4K | ﹤0.01% | 2907 |
|
|
2021
Q3 | $556K | Buy |
14,917
+391
| +3% | +$14.6K | ﹤0.01% | 3106 |
|
|
2021
Q2 | $593K | Buy |
14,526
+837
| +6% | +$34.2K | ﹤0.01% | 2997 |
|
|
2021
Q1 | $464K | Sell |
13,689
-911
| -6% | -$30.9K | ﹤0.01% | 3074 |
|
|
2020
Q4 | $464K | Buy |
14,600
+105
| +0.7% | +$3.34K | ﹤0.01% | 2823 |
|
|
2020
Q3 | $372K | Buy |
14,495
+1,397
| +11% | +$35.9K | ﹤0.01% | 2718 |
|
|
2020
Q2 | $336K | Buy |
13,098
+1,015
| +8% | +$26K | ﹤0.01% | 2732 |
|
|
2020
Q1 | $186K | Sell |
12,083
-4,872
| -29% | -$75K | ﹤0.01% | 2830 |
|
|
2019
Q4 | $582K | Sell |
16,955
-1,018
| -6% | -$34.9K | ﹤0.01% | 2237 |
|
|
2019
Q3 | $134K | Buy |
+17,973
| New | +$134K | ﹤0.01% | 3105 |
|